Laboratory Corp. of America Holdings Given Consensus Recommendation of “Hold” by Analysts (NYSE:LH)
Laboratory Corp. of America Holdings (NYSE:LH) has earned an average rating of “Hold” from the fifteen analysts that are presently covering the company, ARN reports. Nine analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $105.15.
In other Laboratory Corp. of America Holdings news, CEO David P. King sold 65,233 shares of Laboratory Corp. of America Holdings stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $106.10, for a total transaction of $6,921,221.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
A number of research firms have recently commented on LH. Analysts at Zacks reiterated a “neutral” rating on shares of Laboratory Corp. of America Holdings in a research note on Thursday, July 24th. They now have a $111.00 price target on the stock. Separately, analysts at William Blair upgraded shares of Laboratory Corp. of America Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday, July 17th. Finally, analysts at Maxim Group raised their price target on shares of Laboratory Corp. of America Holdings from $110.00 to $120.00 in a research note on Thursday, July 17th. They now have a “buy” rating on the stock.
Laboratory Corp. of America Holdings (NYSE:LH) opened at 107.23 on Wednesday. Laboratory Corp. of America Holdings has a 52 week low of $87.01 and a 52 week high of $108.00. The stock has a 50-day moving average of $104.9 and a 200-day moving average of $100.5. The company has a market cap of $9.104 billion and a price-to-earnings ratio of 17.54.
Laboratory Corp. of America Holdings (NYSE:LH) last released its earnings data on Friday, July 18th. The company reported $1.84 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.77 by $0.07. The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter last year, the company posted $1.80 earnings per share. Laboratory Corp. of America Holdings’s revenue was up 3.3% compared to the same quarter last year. Analysts expect that Laboratory Corp. of America Holdings will post $6.73 EPS for the current fiscal year.
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.
Receive News & Ratings for Laboratory Corp of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp of America Holdings and related companies with Analyst Ratings Network's FREE daily email newsletter.